Gene Expression Profiling and Radiation Toxicity in Cancer Patients
Author Information
Author(s): Svensson J. Peter, Stalpers Lukas J. A, Lange Rebecca E. E. Esveldt–van, Franken Nicolaas A. P, Haveman Jaap, Klein Binie, Turesson Ingela, Vrieling Harry, Giphart-Gassler Micheline
Primary Institution: Leiden University Medical Center
Hypothesis
The cellular response of normal tissue to X-rays could discriminate patients with and without late radiation toxicity.
Conclusion
Gene expression profiling can distinguish groups of patients with and without severe late radiotherapy toxicity, but predicting individual responses needs improvement.
Supporting Evidence
- The gene set classifier improved correct classification to 86%.
- The apoptotic response was more pronounced in patients that did not develop toxicity.
- In an independent set of 12 patients, the toxicity status of eight was predicted correctly by the gene set classifier.
Takeaway
Scientists studied blood samples from cancer patients to see if their genes could help predict who would get sick from radiation treatment. They found some patterns that worked for groups of patients, but not for individuals yet.
Methodology
Blood samples from prostate cancer patients were analyzed for gene expression after X-ray irradiation to classify patients based on their response.
Potential Biases
Potential misclassification of patients based on clinical symptoms rather than genetic predisposition.
Limitations
The study focused on extreme responders, which may limit the generalizability of the findings.
Participant Demographics
Patients were prostate cancer survivors, with 21 having severe late radiation toxicity and 17 without.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% confidence intervals for misclassification rates
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website